VSIR and triple-negative breast carcinoma: The roster of immune checkpoints encompasses an additional constituent, the V-set immunoregulatory receptor (also known as VISTA), which is identified as a crucial immune checkpoint that is influential in the management of various malignancies, particularly triple-negative breast cancer (TNBC) [55].